119 related articles for article (PubMed ID: 28759630)
1. C77G in PTPRC (CD45) is no risk allele for ovarian cancer, but associated with less aggressive disease.
Landskron J; Kraggerud SM; Wik E; Dørum A; Bjørnslett M; Melum E; Helland Ø; Bjørge L; Lothe RA; Salvesen HB; Taskén K
PLoS One; 2017; 12(7):e0182030. PubMed ID: 28759630
[TBL] [Abstract][Full Text] [Related]
2. Altered CD45 expression in C77G carriers influences immune function and outcome of hepatitis C infection.
Dawes R; Hennig B; Irving W; Petrova S; Boxall S; Ward V; Wallace D; Macallan DC; Thursz M; Hill A; Bodmer W; Beverley PC; Tchilian EZ
J Med Genet; 2006 Aug; 43(8):678-84. PubMed ID: 16505159
[TBL] [Abstract][Full Text] [Related]
3. Outcome of children treated with haematopoietic-stem cell transplantations from donors expressing the rare C77G variant of the PTPRC (CD45) gene.
Samaan S; Guérin-El Khourouj V; Auboeuf D; Peltier L; Pédron B; Ouachée-Chardin M; Gourgouillon N; Baruchel A; Dalle JH; Sterkers G
Br J Haematol; 2011 Apr; 153(1):47-57. PubMed ID: 21323873
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of CD45RA isoforms in carriers of the C77G mutation leads to hyporeactivity of CD4+CD25highFoxp3+ regulatory T cells.
Pokoyski C; Lienen T; Rother S; Schock E; Plege-Fleck A; Geffers R; Schwinzer R
Genes Immun; 2015 Dec; 16(8):519-27. PubMed ID: 26355564
[TBL] [Abstract][Full Text] [Related]
5. [Prevalence of C77G polymorphism in exon 4 of the CD45 gene in the Spanish population].
Gil J; Ruiz-Tíscar JL; Rodríguez-Sainz C; Hernández A; Santamaría B; García-Sánchez F; Fernández-Cruz E
Med Clin (Barc); 2005 Jun; 125(1):10-1. PubMed ID: 15960938
[TBL] [Abstract][Full Text] [Related]
6. Unusual case presentations associated with the CD45 C77G polymorphism.
Tchilian EZ; Gil J; Navarro ML; Fernandez-Cruz E; Chapel H; Misbah S; Ferry B; Renz H; Schwinzer R; Beverley PC
Clin Exp Immunol; 2006 Dec; 146(3):448-54. PubMed ID: 17100764
[TBL] [Abstract][Full Text] [Related]
7. The exon A (C77G) mutation is a common cause of abnormal CD45 splicing in humans.
Tchilian EZ; Wallace DL; Imami N; Liao HX; Burton C; Gotch F; Martinson J; Haynes BF; Beverley PC
J Immunol; 2001 May; 166(10):6144-8. PubMed ID: 11342634
[TBL] [Abstract][Full Text] [Related]
8. Altered CD45 isoform expression in C77G carriers influences cytokine responsiveness and adhesion properties of T cells.
Windhagen A; Sönmez D; Hornig-Do HT; Kalinowsky A; Schwinzer R
Clin Exp Immunol; 2007 Dec; 150(3):509-17. PubMed ID: 17903220
[TBL] [Abstract][Full Text] [Related]
9. A CD45 polymorphism associated with abnormal splicing is absent in African populations.
Tchilian EZ; Dawes R; Ramaley PA; Whitworth JA; Yuldasheva N; Wells RS; Watera C; French N; Gilks CF; Kunachiwa W; Ruzibakiev R; Leetrakool N; Carrington CV; Ramdath DD; Gotch F; Stephens HA; Hill AV; Beverley PC
Immunogenetics; 2002 Feb; 53(10-11):980-3. PubMed ID: 11862398
[TBL] [Abstract][Full Text] [Related]
10. PTPRC (CD45) C77G mutation does not contribute to multiple sclerosis susceptibility in Sardinian patients.
Cocco E; Murru MR; Melis C; Schirru L; Solla E; Lai M; Rolesu M; Marrosu MG
J Neurol; 2004 Sep; 251(9):1085-8. PubMed ID: 15372250
[TBL] [Abstract][Full Text] [Related]
11. A point mutation in the human CD45 gene associated with defective splicing of exon A.
Thude H; Hundrieser J; Wonigeit K; Schwinzer R
Eur J Immunol; 1995 Jul; 25(7):2101-6. PubMed ID: 7621884
[TBL] [Abstract][Full Text] [Related]
12. No association between systemic sclerosis and C77G polymorphism in the human PTPRC (CD45) gene.
Kirsten H; Blume M; Emmrich F; Hunzelmann N; Mierau R; Rzepka R; Vaith P; Witte T; Melchers I; Ahnert P
J Rheumatol; 2008 Sep; 35(9):1817-9. PubMed ID: 18634151
[TBL] [Abstract][Full Text] [Related]
13. CD45 variant alleles: possibly increased frequency of a novel exon 4 CD45 polymorphism in HIV seropositive Ugandans.
Stanton T; Boxall S; Bennett A; Kaleebu P; Watera C; Whitworth J; French N; Dawes R; Hill AV; Bodmer W; Beverley PC; Tchilian EZ
Immunogenetics; 2004 May; 56(2):107-10. PubMed ID: 15057492
[TBL] [Abstract][Full Text] [Related]
14. PTPRC (CD45) variation and disease association studied using single nucleotide polymorphism tagging.
Hennig BJ; Fry AE; Hirai K; Tahara H; Tamori A; Moller M; Hopkin J; Hill AV; Bodmer W; Beverley P; Tchilian E
Tissue Antigens; 2008 May; 71(5):458-63. PubMed ID: 18312479
[TBL] [Abstract][Full Text] [Related]
15. Prolonged expression of high molecular mass CD45RA isoform during the differentiation of human progenitor thymocytes to CD3+ cells in vitro.
Deans JP; Wilkins JA; Caixia S; Pruski E; Pilarski LM
J Immunol; 1991 Dec; 147(12):4060-8. PubMed ID: 1836475
[TBL] [Abstract][Full Text] [Related]
16. Consequences of increased CD45RA and RC isoforms for TCR signaling and peripheral T cell deficiency resulting from heterogeneous nuclear ribonucleoprotein L-like mutation.
Wu Z; Yates AL; Hoyne GF; Goodnow CC
J Immunol; 2010 Jul; 185(1):231-8. PubMed ID: 20505149
[TBL] [Abstract][Full Text] [Related]
17. Abnormal cell surface antigen expression in individuals with variant CD45 splicing and histiocytosis.
Boxall S; McCormick J; Beverley P; Strobel S; De Filippi P; Dawes R; Klersy C; Clementi R; De Juli E; Ferster A; Wallace D; Aricò M; Danesino C; Tchilian E
Pediatr Res; 2004 Mar; 55(3):478-84. PubMed ID: 14630980
[TBL] [Abstract][Full Text] [Related]
18. No association between transmembrane protein-tyrosine-phosphatase receptor type C (CD45) exon A 77C>G transversion and Hashimoto's thyroiditis in a German population.
Thude H; Weissenborn S; Vilser C; Müller UA; Kloos C; Wolf G; Beck J; Barz D
Hum Immunol; 2010 Feb; 71(2):220-3. PubMed ID: 19879912
[TBL] [Abstract][Full Text] [Related]
19. Organization and expression of thirteen alternatively spliced exons in catfish CD45 homologs.
Kountikov E; Wilson M; Miller N; Clem W; Bengtén E
Dev Comp Immunol; 2004 Aug; 28(10):1023-35. PubMed ID: 15236932
[TBL] [Abstract][Full Text] [Related]
20. A novel mutation in PTPRC interferes with splicing and alters the structure of the human CD45 molecule.
Jacobsen M; Hoffmann S; Cepok S; Stei S; Ziegler A; Sommer N; Hemmer B
Immunogenetics; 2002 Jun; 54(3):158-63. PubMed ID: 12073144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
